Slitrk6 binding agents, conjugates thereof, and methods of use thereof

CO20260011271A2Pending Publication Date: 2026-08-31GENMAB AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CO20260011271
Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-10
Filing Date
2026-08-06
Publication Date
2026-08-31
Patent Text Reader

Abstract

The present invention provides SLITRK6 antibodies, antigen-binding portions thereof, other binding agents and SLITRK6 conjugates thereof, as well as methods and uses of said antibodies and conjugates for the treatment of cancer and autoimmune diseases.
Need to check novelty before this filing date? Find Prior Art